Frost & Sullivan

MARCH 22, 2024

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. What is driving transformation in the pharma industry? How are drug discovery companies enhancing R&D and accelerating growth through ecosystem partnerships?

Biopharma 52

Biopharma Ecosystems Biotech Contract research organization 52

Frost & Sullivan

FEBRUARY 15, 2024

Small- to mid-sized pharma/biotech players in APAC are rivaling Europe in clinical trials through multiple CRO partnerships in the region, tapping into a population-rich landscape. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.

Ecosystems 40

Ecosystems Contract research organization Biotech Utilities 40

Frost & Sullivan

FEBRUARY 6, 2023

Collaborations and R&D investment in advanced therapies – Bio-CDMOs like Piramal Pharma Limited can align themselves as co-development partners for antibody drug conjugates (ADCs), whereas emerging biotech like Regrow Biosciences continues to focus on the innovation and commercialization of cell therapies.

Life science 52

Life science Biotech Ecosystems Finance 52

Frost & Sullivan

MARCH 5, 2025

Middle East: Governments are building closed-loop battery recycling ecosystems , attracting global recyclers like Li-Cycle and Umicore. Investment Outlook: Biohybrid technologies will see strong adoption in biotech, environmental science, and smart wearables. Explore the latest innovations and strategies driving growth.

Biotech 52

Biotech Energy Fintech Construction 52

Frost & Sullivan

MARCH 28, 2025

Competitive Landscape: Industry Players and Ecosystem The global cardiac biomarkers diagnostics market is moderately competitive, with major players driving innovation. The adoption of advanced diagnostic technologies, including high-sensitivity assays and POCT, is expected to drive market growth in this region over the forecast period.

Biotechnology 52

Biotechnology Biotech Ecosystems 52

Frost & Sullivan

JANUARY 23, 2025

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors.

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52